While one in three of us will be hit with cancer in our lifetime, we never think it will be us, which is why dealing with cancer is often a tumultuous journey. However, complementary medicine treatment can be integrated with conventional therapies to support you during this challenging time, to support your body physically, especially your immune system, as well as providing emotional support.
Remède’s practitioners that are experienced in cancer support are truly committed to working together with the patient and their oncologist or general practitioner, to ensure that treatments work synergistically (and are not contraindicated) – to ensure optimal patient care and to provide the patient with a truly complementary approach.
Specific anti-cancer dietary and lifestyle guidelines, together with individualised complementary medicines, acupuncture and massage, can be used to enhance the effectiveness of conventional cancer treatment, as well as minimise common side-effects of radiotherapy and chemotherapy treatment, as well as to keep “healthy cells healthy” – especially the immune system.
Your practitioner may also look at state-of-the art testing in cancer treatment such as the Circulating Tumour Cell (CTC) Count test. Escapee cancer cells in the blood, or ‘CTCs’ as they are known, can be found by a simple blood test.
Monitoring changes in cancer activity over time is made easy with this test
A CTC Count is the best way to:
- Monitor the effectiveness of cancer treatment
- Assess changes in cancer aggressiveness
- Determine risk of cancer spread, recurrence or relapse
You practitioner can also arrange Customised Chemosensitivity Testing. Some CTCs can hide in the blood stream for months or years before activating and forming a second tumour. Some CTCs may even resist treatment. This test analyses how a person’s CTCs respond when exposed to a recommended chemotherapy regimen or botanical treatment. CTCs that die or survive exposure are said to be ‘sensitive’ or ‘resistant’ to the tested treatment, respectively.
Recommended therapies can now be tested. Each test is customised specifically for each patient by the requesting practitioner.
Maintrac’s Customised Chemosensitivity test can be used to:
- Analyse if a person’s CTCs are sensitive or resistant to a recommended treatment
- Assist practitioners in deciding on a treatment plan
- Increase confidence in the therapy’s ability to reduce cancer spread effectively
Maintrac is a state-of-the-art German technology that detects, characterises and tests CTCs. It has been critically validated and published in peer reviewed journals for over 12 years. Maintrac CTC tests are acknowledged and utilised by many universities, Oncologists and cancer clinics worldwide.